BioDelivery Sciences Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 178
Employees
  • Stock Symbol
  • BDSI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $4.17
  • (As of Thursday Closing)

BioDelivery Sciences General Information

Description

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, and opioid dependence.

Contact Information

Website
Formerly Known As
Mas Acquisition Xxiii
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 4131 ParkLake Avenue
  • Suite 225
  • Raleigh, NC 27612
  • United States
+1 (919) 000-0000

BioDelivery Sciences Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioDelivery Sciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.17 $4.14 $2.85 - $7.21 $418M 100M 909K -$0.08

BioDelivery Sciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 359,830 625,681 262,595 180,813
Revenue 129,898 111,389 55,640 61,985
EBITDA 20,248 12,567 (17,765) 4,008
Net Income (6,506) (15,305) (33,867) 5,285
Total Assets 196,616 182,905 108,533 88,101
Total Debt 58,634 58,568 51,652 47,660
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioDelivery Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioDelivery Sciences‘s full profile, request access.

Request a free trial

BioDelivery Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated
Pharmaceuticals
Raleigh, NC
178 As of 2019
00000
000000000000 00000

00000000

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
000000000000000
San Diego, CA
0 As of 0000
00000
00000000000 00000

00000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
000000000000000
Saint-Cloud, France
0000 As of 0000
00000
0000 0000-00-00
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioDelivery Sciences Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediciNova Formerly VC-backed San Diego, CA 0 00000 00000000000 00000
000000000 Private Equity-Backed Saint-Cloud, France 0000 00000 000000000000 00000
000000 00000000000 Formerly Angel backed San Diego, CA 00 00.000 000000&0 00.000
000000 00000000000 Venture Capital-Backed Carlsbad, CA 0 000.00 00000000000 000.00
000000 00000000000 Formerly VC-backed Westlake Village, CA 00 00000 0000000000.
You’re viewing 5 of 25 competitors. Get the full list »

BioDelivery Sciences Executive Team (15)

Name Title Board Seat Contact Info
Scott Plesha Executive & President
Mary Theresa Coelho Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
James Vollins General Counsel, Legal & Secretary, Administration
Thomas Smith Chief Medical Officer
Jeffrey Bailey Chief Executive Officer & Board Member
You’re viewing 5 of 15 executive team members. Get the full list »

BioDelivery Sciences Board Members (15)

Name Representing Role Since
0000000 000000 Self Chief Executive Officer & Board Member 000 0000
00000 000000 Self Board Member 000 0000
0000 00000 00.0 Self Board Member & Vice Chairman 000 0000
00000 000000000 Self Chairman & Board Member 000 0000
0000 00000 Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

BioDelivery Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioDelivery Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioDelivery Sciences‘s full profile, request access.

Request a free trial

BioDelivery Sciences Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 08-Dec-2016 000000000000000000 Other Healthcare 0000 00000 00.0
Arius Pharmaceuticals 24-Aug-2004 Merger/Acquisition Pharmaceuticals 0000000 0'0000000 00.
To view BioDelivery Sciences’s complete acquisitions history, request access »

BioDelivery Sciences Subsidiaries (1)

Company Name Industry Location Founded
0000000 Other Healthcare Raleigh, NC
To view BioDelivery Sciences’s complete subsidiaries history, request access »